Filtered By:
Infectious Disease: Outbreaks
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 533 results found since Jan 2013.
Leading in Time of COVID: A True Test of Leadership
By Folake OlayinkaAug 15 2020 (IPS) In 1918, the Spanish Flu, a deadly influenza caused by the H1N1 virus, decimated the world. Over the course of four successive waves, it infected 500 million people, about a third of the world’s population at the time, resulting in 50 million deaths.
More recently between 2014 and mid-2016 , the Ebola virus epidemic was the most widespread outbreak of Ebola virus disease in history—causing devastating loss of life and socioeconomic disruption in the West Africa region, mainly in Guinea, Liberia and Sierra Leone. These outbreaks, as well as SARS and MERS, each have provided lessons...
Source: IPS Inter Press Service - Health - August 15, 2020 Category: International Medicine & Public Health Authors: Folake Olayinka Tags: Democracy Headlines Health Source Type: news
Why the U.S. Is Losing the War On COVID-19
It is a frightening time to live in the United States. COVID-19, a novel disease as ruthless as it is seemingly random, is picking us off by the thousands; even many of those who “recover” may never truly be the same again. The pandemic has exposed the gulf between what this country promises for its citizens and what it actually delivers. And as the U.S. barrels toward Election Day, the outbreak is sure to complicate the voting process, with potentially disastrous results.
For a short time in the spring, it appeared the U.S. was getting a grip on its outbreak. Hard-hit states like New York successfully flattene...
Source: TIME: Science - August 13, 2020 Category: Science Authors: Alex Fitzpatrick Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news
The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries
AbstractPurpose of ReviewOlfactory dysfunction in upper airway viral infections (common cold, acute rhinosinusitis) is common (> 60%). During the COVID-19 outbreak, frequency of sensory disorders (smell and/or taste) in affected patients has shown a high variability from 5 to 98%, depending on the methodology, country, and study.Recent FindingsA sudden, severe, isolated loss of smell and/or taste, in the absence of other upper airway inflammatory diseases (allergic rhinitis, chronic rhinosinusitis, nasal polyposis), should alert individuals and physicians on being potentially affected by COVID-19. The evaluation of s...
Source: Current Allergy and Asthma Reports - August 2, 2020 Category: Allergy & Immunology Source Type: research
Contact Tracing Is Failing in Many States. Here ’s Why.
Inadequate testing and protracted delays in producing results have crippled tracking and hampered efforts to contain major outbreaks.
Source: NYT Health - July 31, 2020 Category: Consumer Health News Authors: Jennifer Steinhauer and Abby Goodnough Tags: Contact Tracing (Public Health) Tests (Medical) Coronavirus (2019-nCoV) States (US) Medicine and Health Centers for Disease Control and Prevention National Institute of Allergy and Infectious Diseases Arizona Austin (Tex) California Fl Source Type: news
Moderna ’s COVID-19 Vaccine Enters Final Testing Phase, As Researchers Dose the Study’s First Volunteer
Moderna Therapeutics and the National Institute of Allergy and Infectious Diseases (NIAID) announced today that researchers had injected the first volunteer in the first U.S. coronavirus vaccine to reach the final, phase 3 stage of testing.
That person received the shot at 6:45 am eastern time in Savannah, Geo., Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) told reporters during a briefing. Because the trial will randomly assign participants to receive either the vaccine or a placebo, and neither the researchers nor the volunteers will kn...
Source: TIME: Health - July 27, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Fauci: US is ‘still knee-deep in first wave’ of pandemic as it passes 130,000 deaths
Top public health expert urges further action as new cases surge to record highs of around 50,000 a day across countryThe United States is “still knee-deep in the first wave” of the coronavirus pandemic, one of the country’s top public health experts has warned, as the country surpassed130,000 Covid-19 deaths andnew polling indicates Donald Trump ’s approval rating over his handling of the crisis has remained low.Dr Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said on Monday that America ’s grasp of the pandemic was “really not good” and urged further action as new...
Source: Guardian Unlimited Science - July 7, 2020 Category: Science Authors: Oliver Laughland in New Orleans Tags: Coronavirus outbreak Science US news US politics Donald Trump Trump administration Source Type: news
Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Abstract
As the COVID-19 pandemic gradually comes under control, the members of the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC) have drawn up a proposed list of the requirements, limitations, and conditioning factors affecting the resumption of work in contact dermatitis units. The assumption is that the severe acute respiratory syndrome coronavirus 2 is still circulating and that occasional or seasonal outbreaks will occur. They recommend that the first step should be to assess how many patch tests each clinic can handle and review the waiting list to prioritize cases according to disease ...
Source: Actas Dermo-Sifiliograficas - July 1, 2020 Category: Dermatology Authors: Carrascosa JM, Pastor-Nieto MA, Ruiz-Gonzalez I, Silvestre JF, Borrego L, Gatica-Ortega ME, Gimenez-Arnau AM, en representación del, Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) Tags: Actas Dermosifiliogr Source Type: research
Johnson & Johnson Announces European Commission Approval for Janssen ’s Preventive Ebola Vaccine
Discussions with the U.S. Food and Drug Administration (FDA) have taken place to define the required data set for filing US licensure. About Janssen’s Ebola Vaccine Regimen The Janssen preventive Ebola vaccine regimen, Ad26.ZEBOV and MVA-BN-Filo, utilizes a non-replicating viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors carry the genetic code of several Ebola virus proteins in order to trigger an immune response.Janssen’s vaccine regimen ori...
Source: Johnson and Johnson - July 1, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Lack of Complications in Patients with Eosinophilic Gastrointestinal Diseases During SARS-CoV-2 Outbreak
Publication date: Available online 29 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Edoardo Savarino, Greta Lorenzon, Matteo Ghisa, Giorgio Laserra, Brigida Barberio, Daria Maniero Sc, Vincenzo Savarino, Fabiana Zingone
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 30, 2020 Category: Allergy & Immunology Source Type: research
Dupilumab As a Novel Therapy To Treat Adrenergic Urticaria
Adrenergic urticaria (AU) is a rare and infrequently reported disease that presents with intermittent outbreaks of stress-induced diffuse pruritic urticarial papules. First described in 19851, there has been growing literature further elucidating the mechanism of the disease as well as novel therapeutic options. A frequently occurring challenge in the diagnosis of AU is differentiating it from the more common cholinergic urticaria (CU). While in AU the papules are surrounded by halos of hypopigmented and vasoconstricted skin, in CU the small papules are surrounded by large red flares2.
Source: Annals of Allergy, Asthma and Immunology - June 29, 2020 Category: Allergy & Immunology Authors: Brian Goodman, Sunit Jariwala Tags: Letters Source Type: research
Reply
We read with interest the relevant comment of Gallo et al1 concerning our recent Editorial.2 Globally, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has upset the lifestyle of humans, increasing sedentary behaviors with quarantine (ie, staying at home, tele-working, screen activities), the fear of contagion (ie, social conn ections, mass transit, and compulsive disinfecting), and probably a city dweller migration to the periphery of crowed cities and surrounding countryside.
Source: Journal of Allergy and Clinical Immunology - June 21, 2020 Category: Allergy & Immunology Authors: Valentin Navel, Fr édéric Chiambaretta, Frédéric Dutheil Tags: Correspondence Source Type: research
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
We read with great interest the article “Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan” by Li et al,1 one of the most detailed studies in terms of patients’ clinical characterization.
Source: Journal of Allergy and Clinical Immunology - June 21, 2020 Category: Allergy & Immunology Authors: Marco Caminati, Carlo Lombardi, Claudio Micheletto, Elena Roca, Barbara Bigni, Fabiana Furci, Domenico Girelli, Gianenrico Senna, Ernesto Crisafulli Tags: Correspondence Source Type: research
COVID-19 - guidance for acute settings, RCPCH (updated 18th June 2020)
This page provides guidance for paediatric emergency and acute settings. It has been produced with the Association of Paediatric Emergency Medicine (APEM) and the British Paediatric Allergy, Immunity and Infection Group (BPAIIG).
Updates in this version (18 June 2020)
Added link to RCPCH 2 External 0 0 0 guidance on resuscitation false https://www.rcpch.ac.uk/resources/covid-19-resuscitation-guide false false%>. Added link to 2 External 0 0 0 guidance for hospital visitors false https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/new-government-recommendations-...
Source: Current Awareness Service for Health (CASH) - June 19, 2020 Category: Consumer Health News Source Type: news
